Sovleplenib in patients with primary or secondary warm autoimmune haemolytic anaemia: results from phase 2 of a randomised, double-blind, placebo-controlled, phase 2/3 study.
Zhao X, Sun J, Zhang Z, Chen M, Gong T, He G, Li Y, Liu H, Li F, Li X, Zhou H, Wang X, Hong M, Lei L, Yin H, Luo X, Li Y, Fan S, Guo X, Shi MM, Su W, Zhang L, Han B, Zhang F.
Zhao X, et al. Among authors: chen m.
Lancet Haematol. 2025 Jan 9:S2352-3026(24)00344-2. doi: 10.1016/S2352-3026(24)00344-2. Online ahead of print.
Lancet Haematol. 2025.
PMID: 39799953